May 14, 2020 / 11:19 AM / 13 days ago

BRIEF-Kitov To Present Phase 1 Data On Cm-24 In Patients With Advanced Cancer At ASCO 2020 Virtual Scientific Program

May 14 (Reuters) - Kitov Pharma Ltd:

* KITOV TO PRESENT PHASE 1 DATA ON CM-24 IN PATIENTS WITH ADVANCED CANCER AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2020 VIRTUAL SCIENTIFIC PROGRAM

* KITOV PHARMA - EXPECTS TO INITIATE PHASE 1/2 CLINICAL TRIAL, WITH BRISTOL MYERS SQUIBB, WITH CM-24 IN COMBINATION WITH NIVOLUMAB (OPDIVO®) IN H2 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below